FOAMIX PHARMACEUTICALS LTD's ticker is FOMX and the CUSIP is M46135105. A total of 83 filers reported holding FOAMIX PHARMACEUTICALS LTD in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2017 | $188,000 | -49.7% | 37,988 | -35.6% | 0.00% | -33.3% |
Q2 2016 | $374,000 | -31.9% | 58,964 | -29.9% | 0.00% | -40.0% |
Q1 2016 | $549,000 | -19.5% | 84,134 | 0.0% | 0.01% | -28.6% |
Q4 2015 | $682,000 | +520.0% | 84,134 | +460.9% | 0.01% | +600.0% |
Q3 2015 | $110,000 | -28.6% | 15,000 | 0.0% | 0.00% | -50.0% |
Q2 2015 | $154,000 | – | 15,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DSC Advisors, L.P. | 1,000,000 | $7,330,000 | 3.56% |
Sio Capital Management, LLC | 336,286 | $2,465,000 | 1.69% |
Opaleye Management Inc. | 285,000 | $2,089,000 | 1.03% |
SENZAR ASSET MANAGEMENT, LLC | 864,408 | $6,336,111,000 | 0.92% |
MENORA MIVTACHIM HOLDINGS LTD. | 1,350,847 | $9,902,000 | 0.74% |
Ghost Tree Capital, LLC | 150,000 | $1,100,000 | 0.50% |
PURA VIDA INVESTMENTS, LLC | 102,000 | $748,000 | 0.43% |
SPHERA FUNDS MANAGEMENT LTD. | 380,000 | $2,785,000 | 0.36% |
J. Goldman & Co LP | 474,810 | $3,480,000 | 0.30% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 948,934 | $6,956,000 | 0.27% |